These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 16247516)
21. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells. Nagata A; Tanaka T; Minezawa A; Poyurovsky M; Mayama T; Suzuki S; Hashimoto N; Yoshida T; Suyama K; Miyata A; Hosokawa H; Nakayama T; Tatsuno I J Cell Physiol; 2009 Oct; 221(1):75-83. PubMed ID: 19496170 [TBL] [Abstract][Full Text] [Related]
22. Ventilatory and cardiovascular actions of centrally and peripherally administered trout pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) in the unanaesthetized trout. Le Mével JC; Lancien F; Mimassi N; Conlon JM J Exp Biol; 2009 Dec; 212(Pt 23):3919-27. PubMed ID: 19915135 [TBL] [Abstract][Full Text] [Related]
23. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland. Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952 [TBL] [Abstract][Full Text] [Related]
24. Mechanisms of VIP-induced neuroprotection against neonatal excitotoxicity. Rangon CM; Dicou E; Goursaud S; Mounien L; Jégou S; Janet T; Muller JM; Lelièvre V; Gressens P Ann N Y Acad Sci; 2006 Jul; 1070():512-7. PubMed ID: 16888217 [TBL] [Abstract][Full Text] [Related]
26. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor. Tachibana T; Saito ES; Takahashi H; Saito S; Tomonaga S; Boswell T; Furuse M Regul Pept; 2004 Aug; 120(1-3):99-105. PubMed ID: 15177926 [TBL] [Abstract][Full Text] [Related]
27. PACAP and its receptors in cranial arteries and mast cells. Jansen-Olesen I; Hougaard Pedersen S J Headache Pain; 2018 Feb; 19(1):16. PubMed ID: 29460121 [TBL] [Abstract][Full Text] [Related]
28. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex. Zawilska JB; Niewiadomski P; Nowak JZ Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071 [TBL] [Abstract][Full Text] [Related]
29. PACAP and PAC1 receptor in brain development and behavior. Shen S; Gehlert DR; Collier DA Neuropeptides; 2013 Dec; 47(6):421-30. PubMed ID: 24220567 [TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical localization of the VIP1 receptor (VPAC1R) in rat cerebral blood vessels: relation to PACAP and VIP containing nerves. Fahrenkrug J; Hannibal J; Tams J; Georg B J Cereb Blood Flow Metab; 2000 Aug; 20(8):1205-14. PubMed ID: 10950381 [TBL] [Abstract][Full Text] [Related]
31. Early Alterations of PACAP and VIP Expression in the Female Rat Brain Following Spinal Cord Injury. Broome ST; Mandwie M; Gorrie CA; Musumeci G; Marzagalli R; Castorina A J Mol Neurosci; 2023 Oct; 73(9-10):724-737. PubMed ID: 37646964 [TBL] [Abstract][Full Text] [Related]
32. Analysis of the role of the PAC1 receptor in neutrophil recruitment, acute-phase response, and nitric oxide production in septic shock. Martínez C; Juarranz Y; Abad C; Arranz A; Miguel BG; Rosignoli F; Leceta J; Gomariz RP J Leukoc Biol; 2005 May; 77(5):729-38. PubMed ID: 15661828 [TBL] [Abstract][Full Text] [Related]
33. Role of VIP and PACAP in islet function. Winzell MS; Ahrén B Peptides; 2007 Sep; 28(9):1805-13. PubMed ID: 17559974 [TBL] [Abstract][Full Text] [Related]
34. All D-VIP mitigates vasodilation elicited by L-VIP, micellar L-VIP and micellar PACAP1-38, but not PACAP1-38, in vivo. Rubinstein I; Ashok B; Tsueshita T; Onyüksel H Peptides; 2005 Mar; 26(3):509-15. PubMed ID: 15652658 [TBL] [Abstract][Full Text] [Related]
35. Endogenous inhibition of hippocampal LTD and depotentiation by vasoactive intestinal peptide VPAC1 receptors. Cunha-Reis D; Aidil-Carvalho Mde F; Ribeiro JA Hippocampus; 2014 Nov; 24(11):1353-63. PubMed ID: 24935659 [TBL] [Abstract][Full Text] [Related]
36. Ageing and the diurnal expression of mRNAs for vasoactive intestinal peptide and for the VPAC2 and PAC1 receptors in the suprachiasmatic nucleus of male rats. Kalló I; Kalamatianos T; Piggins HD; Coen CW J Neuroendocrinol; 2004 Sep; 16(9):758-66. PubMed ID: 15344914 [TBL] [Abstract][Full Text] [Related]
37. Role of VPAC1 and VPAC2 in VIP mediated inhibition of rat pulmonary artery and aortic smooth muscle cell proliferation. St Hilaire RC; Murthy SN; Kadowitz PJ; Jeter JR Peptides; 2010 Aug; 31(8):1517-22. PubMed ID: 20452385 [TBL] [Abstract][Full Text] [Related]
38. Modulation of AMPA receptor-mediated ion current by pituitary adenylate cyclase-activating polypeptide (PACAP) in CA1 pyramidal neurons from rat hippocampus. Costa L; Santangelo F; Li Volsi G; Ciranna L Hippocampus; 2009 Jan; 19(1):99-109. PubMed ID: 18727050 [TBL] [Abstract][Full Text] [Related]
39. Calmodulin interacts with PAC1 and VPAC2 receptors and regulates PACAP-induced FOS expression in human neuroblastoma cells. Falktoft B; Georg B; Fahrenkrug J Neuropeptides; 2009 Apr; 43(2):53-61. PubMed ID: 19269029 [TBL] [Abstract][Full Text] [Related]
40. Differential Expression of PACAP/VIP Receptors in the Post-Mortem CNS White Matter of Multiple Sclerosis Donors. Jansen MI; Musumeci G; Castorina A Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201536 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]